These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 14239975)

  • 1. BLOOD LOSS ASSOCIATED WITH ADMINISTRATION OF LOW MOLECULAR WEIGHT DEXTRAN.
    GARZON AA; FINK LH; SHAFTAN GW; KARLSON KE
    J Thorac Cardiovasc Surg; 1964 Dec; 48():873-80. PubMed ID: 14239975
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDY OF THE ANTI-THROMBOTIC PROPERTIES OF DEXTRANS OF LARGE MOLECULAR WEIGHT.
    BRYANT MF; BLOOM WL; BREWER SS
    J Cardiovasc Surg (Torino); 1964; 5():48-52. PubMed ID: 14109832
    [No Abstract]   [Full Text] [Related]  

  • 3. FURTHER STUDIES ON THE EFFECT OF DEXTRAN OF VARIOUS MOLECULAR WEIGHT ON THE COAGULATION MECHANISM.
    NILSSON IM; EIKEN O
    Thromb Diath Haemorrh; 1964 Apr; 11():38-50. PubMed ID: 14167114
    [No Abstract]   [Full Text] [Related]  

  • 4. FIBRINOGEN DESTRUCTION IN THE CADAVER: EFFECT OF ANTEMORTEM STRESS AND INHIBITORS.
    MCKENZIE JM; CELANDER DR; GUEST MM
    Am J Physiol; 1965 May; 208():1009-15. PubMed ID: 14286840
    [No Abstract]   [Full Text] [Related]  

  • 5. COAGULATION STUDIES ON BLOOD FROM THE RIGHT AND LEFT SIDES OF THE HEART.
    PATE JW; DUGDALE M
    Am J Surg; 1964 Jun; 107():861-2. PubMed ID: 14169016
    [No Abstract]   [Full Text] [Related]  

  • 6. IN VITRO--PRECIPITATIONS IN PLASMA BY LOW MOLECULAR WEIGHT DEXTRAN.
    KROLL J; DYBKAER R
    Scand J Clin Lab Invest; 1964; 16():31-8. PubMed ID: 14124449
    [No Abstract]   [Full Text] [Related]  

  • 7. CHYMORAL AND COAGULATION.
    PESSEREAU G; MONTEIL R
    Rev Int Serv Sante Armees; 1963 Dec; 36():745-57. PubMed ID: 14102522
    [No Abstract]   [Full Text] [Related]  

  • 8. TOXICITY OF HEPARINOIDS, WITH SPECIAL REFERENCE TO THE PRECIPITATION OF FIBRINOGEN.
    SASAKI S; TAKEMOTO T; OKA S
    Thromb Diath Haemorrh; 1964 Oct; 12():232-61. PubMed ID: 14224636
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of the interrelationships between fibrinogen and polysaccharides in various pathological states. I. Contribution to the study of the influence of dextran on fibrinogen].
    STOICHITA M; TEICAN-GHEORGHIU M
    Stud Cercet Med Interna; 1962; 3():741-7. PubMed ID: 13984284
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE EFFECT OF SERUM AND PLASMA FACTORS OF NORMAL BLOOD ON THE SPREADING OF THROMBOCYTES].
    MARX R
    Klin Wochenschr; 1964 Jul; 42():650. PubMed ID: 14248617
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased blood loss associated with administration of certain plasma expanders: dextran 75, dextran 40, and hydroxyethyl starch.
    Karlson KE; Garzon AA; Shaftan GW; Chu CJ
    Surgery; 1967 Oct; 62(4):670-8. PubMed ID: 6058021
    [No Abstract]   [Full Text] [Related]  

  • 12. Biophysical studies of blood plasma proteins; the effect of fibrinogen on prothrombin time.
    DEUTSCH HF; GERARDE HW
    J Biol Chem; 1946 Nov; 166(1):381-8. PubMed ID: 20273704
    [No Abstract]   [Full Text] [Related]  

  • 13. INFLUENCE OF MANNITOL AND LOW MOLECULAR WEIGHT DEXTRAN UPON RENAL BLOOD FLOW.
    JUDD D; HERENDEEN T; SHUMACKER HB
    Surgery; 1964 Sep; 56():529-32. PubMed ID: 14215711
    [No Abstract]   [Full Text] [Related]  

  • 14. THE RENAL EXCRETION OF LOW MOLECULAR WEIGHT DEXTRAN.
    ARTRUSON G; GRANATH K; THOREN L; WALLENIUS G
    Acta Chir Scand; 1964 May; 127():543-51. PubMed ID: 14169784
    [No Abstract]   [Full Text] [Related]  

  • 15. [ON QUANTITATIVE CHANGES IN FIBRINOGEN AND METHODS OF THEIR EXAMINATION].
    BALUDA VP; RUSAKOVA GP; TOKAREV OIu
    Lab Delo; 1964; 10():425-9. PubMed ID: 14258534
    [No Abstract]   [Full Text] [Related]  

  • 16. THE EFFECT OF HEPARIN AND EPSILON-AMINOCAPROIC ACID ON THE COAGULATION IN HYPOTHERMIC DOGS.
    JOHANSSON BW; NILSSON IM
    Acta Physiol Scand; 1964 Mar; 60():267-77. PubMed ID: 14131840
    [No Abstract]   [Full Text] [Related]  

  • 17. [A SIMPLE MODIFICATION OF THE 1-STEP PROCEDURE FOR DETERMINATION OF THROMBIN TIME, QUANTITY OF FIBRINOGEN AND FIBRINOLYTIC ACTIVITY OF THE BLOOD].
    KUZNIK BI
    Vopr Med Khim; 1964; 10():316-8. PubMed ID: 14221560
    [No Abstract]   [Full Text] [Related]  

  • 18. [METHOD OFSTUDY OF BLOOD COAGULATION BASED ON THE CHANGES IN ELECTRIC RESISTANCE OF THE FIBRINNETWORK].
    BAYOBAYO JM; ZULUAGAJARAMILLO E
    Arch Inst Farmacol Exp (Madr); 1963; 15():75-93. PubMed ID: 14049389
    [No Abstract]   [Full Text] [Related]  

  • 19. THE ROLE OF LOW MOLECULAR WEIGHT DEXTRAN IN THE MANAGEMENT OF VENOUS THROMBOSIS.
    ERNST CB; FRY WJ; DEWEESE MS; KRAFT RO
    Surg Gynecol Obstet; 1964 Dec; 119():1243-7. PubMed ID: 14227749
    [No Abstract]   [Full Text] [Related]  

  • 20. Disordered blood coagulation in burned children receiving high molecular weight dextran.
    Thomas T; Morris A; Rose MS
    J Clin Pathol; 1972 Jun; 25(6):473-7. PubMed ID: 5043372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.